Treviño Lindsey S, Bolt Michael J, Grimm Sandra L, Edwards Dean P, Mancini Michael A, Weigel Nancy L
Departments of Molecular and Cellular Biology (L.S.T., M.J.B., S.L.G., D.P.E., M.A.M., N.L.W.) and Pathology and Immunology (S.L.G., D.P.E.), Baylor College of Medicine, Houston, Texas 77030.
Mol Endocrinol. 2016 Feb;30(2):158-72. doi: 10.1210/me.2015-1144. Epub 2015 Dec 11.
Progesterone receptor (PR) function is altered by cell signaling, but the mechanisms of kinase-specific regulation are not well defined. To examine the role of cell signaling in the regulation of PR transcriptional activity, we have utilized a previously developed mammalian-based estrogen-response element promoter array cell model and automated cell imaging and analysis platform to visualize and quantify effects of specific kinases on different mechanistic steps of PR-mediated target gene activation. For these studies, we generated stable estrogen-response element array cell lines expressing inducible chimeric PR that contains a swap of the estrogen receptor-α DNA-binding domain for the DNA-binding domain of PR. We have focused on 2 kinases important for steroid receptor activity: cyclin-dependent kinase 2 and DNA-dependent protein kinase. Treatment with either a Cdk1/2 inhibitor (NU6102) or a DNA-dependent protein kinase inhibitor (NU7441) decreased hormone-mediated chromatin decondensation and transcriptional activity. Further, we observed a quantitative reduction in the hormone-mediated recruitment of select coregulator proteins with NU6102 that is not observed with NU7441. In parallel, we determined the effect of kinase inhibition on hormone-mediated induction of primary and mature transcripts of endogenous genes in T47D breast cancer cells. Treatment with NU6102 was much more effective than NU7441, in inhibiting induction of PR target genes that exhibit a rapid increase in primary transcript expression in response to hormone. Taken together, these results indicate that the 2 kinases regulate PR transcriptional activity by distinct mechanisms.
孕激素受体(PR)的功能会因细胞信号传导而改变,但激酶特异性调节的机制尚未明确。为了研究细胞信号传导在PR转录活性调节中的作用,我们利用了先前开发的基于哺乳动物的雌激素反应元件启动子阵列细胞模型以及自动化细胞成像和分析平台,以可视化和量化特定激酶对PR介导的靶基因激活不同机制步骤的影响。在这些研究中,我们构建了稳定的雌激素反应元件阵列细胞系,其表达可诱导的嵌合PR,该嵌合PR包含将雌激素受体α的DNA结合结构域替换为PR的DNA结合结构域。我们重点研究了对类固醇受体活性重要的两种激酶:细胞周期蛋白依赖性激酶2和DNA依赖性蛋白激酶。用Cdk1/2抑制剂(NU6102)或DNA依赖性蛋白激酶抑制剂(NU7441)处理可降低激素介导的染色质解聚和转录活性。此外,我们观察到用NU6102处理后,激素介导的某些共调节蛋白募集出现定量减少,而用NU7441处理则未观察到这种情况。同时,我们确定了激酶抑制对内源性基因在T47D乳腺癌细胞中激素介导的初级转录本和成熟转录本诱导的影响。在抑制PR靶基因的诱导方面,用NU6102处理比用NU7441处理有效得多,这些靶基因在激素刺激下初级转录本表达迅速增加。综上所述,这些结果表明这两种激酶通过不同机制调节PR转录活性。